Thus, with the expression of the mutated human MAPT, APP, and PSEN1 genes, the LaFerla team succeeded in obtaining 3xTg mice developing both amyloid plaques and NFTs [199]. The gene discussed is MAPT; the disease is Neurofibrillary tangles.